Medical Care

Care That Works

Breaking News
New Trials Extend Survival Across Multiple Cancers
Clinic Access

New Trials Extend Survival Across Multiple Cancers

New phase 3 cancer trial results show longer survival for several tumor types, with ivonescimab achieving a median survival of 30.8 months in NSCLC.

By Calliope Ravenswood Oct 2, 2026

Care Protocols

View All

Clinic Access

Woman billed after leaving emergency room untreated
Clinic Access

Woman billed after leaving emergency room untreated

Woman receives $410 bill after leaving emergency room untreated due to severe migraine symptoms.

By Isadora Pembridge Oct 8, 2026

Home Care

View All

Hospital Reviews

All Stories

Patient Guides

All Stories

All Post

Woman billed after leaving emergency room untreated

Woman billed after leaving emergency room untreated

By Isadora Pembridge October 8, 2026
Woman receives $410 bill after leaving emergency room untreated due to severe migraine symptoms.
Medicaid Work Rules Set to Cut Coverage 2027

Medicaid Work Rules Set to Cut Coverage 2027

By Calliope Ravenswood October 7, 2026
Medicaid work rules set to cut coverage by 2027, a change that could disproportionately harm low- and middle-income workers who rely on the program.
Early Hormone Therapy Cuts Heart Risk in Menopause

Early Hormone Therapy Cuts Heart Risk in Menopause

By Thessaly Foxglove October 6, 2026
Early hormone therapy can lower heart disease risk for menopausal women, offering relief for hot flashes and night sweats while easing health worries.
Metastatic breast cancer patients left behind by awareness campaigns

Metastatic breast cancer patients left behind by awareness campaigns

By Isadora Pembridge October 5, 2026
Metastatic breast cancer patients feel excluded from awareness campaigns like Pinktober, despite billions raised for research—discover why funding priorities mi
FDA approves new first-line pill for CLL and SLL

FDA approves new first-line pill for CLL and SLL

By Thessaly Foxglove October 3, 2026
FDA approves Jaypirca (pirtobrutinib) as the first noncovalent BTK inhibitor for frontline CLL and SLL treatment in patients without 17p deletion.
New Trials Extend Survival Across Multiple Cancers

New Trials Extend Survival Across Multiple Cancers

By Calliope Ravenswood October 2, 2026
New phase 3 cancer trial results show longer survival for several tumor types, with ivonescimab achieving a median survival of 30.8 months in NSCLC.
Three-Week Post-Mastectomy Radiation Equal to Five-Week

Three-Week Post-Mastectomy Radiation Equal to Five-Week

By Calliope Ravenswood October 1, 2026
New 10-year data shows three-week post-mastectomy radiation equals five-week cancer control for high-risk breast cancer patients, per ASTRO 2026 findings.
AI helps doctors with cancer care questions

AI helps doctors with cancer care questions

By Thessaly Foxglove September 30, 2026
AI helps doctors with cancer care questions, potentially extending beyond oncologists and cancer specialists.
Woman battles stage 4 lymphoma diagnosis

Woman battles stage 4 lymphoma diagnosis

By Thessaly Foxglove September 29, 2026
Woman battles stage 4 lymphoma diagnosis with aggressive treatment options for non-Hodgkin lymphoma.
Bronx Author Finds Faith After Lung Cancer Diagnosis

Bronx Author Finds Faith After Lung Cancer Diagnosis

By Calliope Ravenswood September 28, 2026
Bronx author discovers lung cancer faith after a 2023 diagnosis, sharing her journey from a Santería-rich upbringing to embracing Christianity.
1 2 3 … 10
© 2026 Medical Care. All rights reserved.